mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
MG-132 |
GDSC1000 |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
Vinorelbine |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |